GHRP-2

    • GHRP-2

    GHRP-2, also known as Pralmorelin (also available in 10mg), is a synthetic growth hormone secretagogue that researchers believe may interact with the ghrelin/growth hormone secretagogue receptors on pituitary cells. It is a pentapeptide composed of five amino acids and is similar to the endogenous neurotransmitter methionine-endorphin. It has been suggested that GHRP-2 may not function as a typical neurotransmitter, although uncertainty remains. Instead, it is speculated that it interacts with the ghrelin receptors. Ghrelin is a hormone that regulates appetite and may be affected by interaction with GHRP-2. It has been speculated that GHRP-2 may induce growth hormone (GH) secretion through a potential interaction with ghrelin receptors on the pituitary, specifically growth hormone secretagogue receptors (GHS-Rs). However, the nature of this interaction is still under investigation and has not yet been conclusively determined. Extensive research has also been conducted to evaluate its role in regulating various physiological processes, including muscle development, appetite, immune function, and sleep cycles.

    $30/1kit


    Contact us
    Category:
    GHRP-2 Research

    GHRP-2 and Muscle Structure


    Studies in yaks have shown that the GHRP-2 peptide appears to stimulate muscle growth in two ways: by enhancing protein synthesis and accumulation, and by reducing protein degradation. [3] Studies have shown that GHRP-2 may help overcome natural growth limitations in yaks due to food deprivation, adverse environmental conditions, and disease. The researchers also suggest that "GHRP-2 enhances muscle protein deposition primarily by upregulating protein synthesis pathways." The most important observation is that GHRP-2 may reduce muscle atrophy by inhibiting atrogin-1 and MuRF1 proteins, which are thought to regulate muscle degradation pathways.

    GHRP-2 and the Heart


    Studies in fetal heart cell culture lines have suggested that GHRP-2 and its analogs (GHRP-1 and GHRP-6) may help protect heart cells by minimizing apoptosis, or programmed cell death. [4] The peptide appears to protect the heart muscle from reduced blood and nutrient supply, which in some cases can trigger cardiac arrest. Studies of the GHRP-2 analog Hexarelin have shown that these peptides associate with specific receptors. It has been hypothesized that the receptor CD36 may play a prominent role in the binding of oxidized low-density lipoprotein (OxLDL). There appears to be an interaction between GHRP-2 and CD36 that may result in a reduction in the uptake of OxLDL by cells, which is thought to be involved in the development of atherosclerosis, characterized by reduced blood and nutrient flow. Preliminary findings suggest that GHRP-2 may reduce interferon-gamma levels by approximately 66% in cultured aortic smooth muscle cells, a model used to study the effects of atherosclerosis. Although GHRP-2 does not appear to significantly alter the extent of atherosclerotic plaque formation, it is suggested that the peptide may reduce superoxide production within vascular tissue. In addition, GHRP-2 has been reported to reduce the gene expression of 12/15-lipoxygenase by nearly 92% and may also reduce the levels of interferon-gamma and macrophage migration inhibitory factor. Experimental observations in cultured aortic smooth muscle cells suggest that GHRP-2 may inhibit OxLDL-induced superoxide production, mitigate downregulation of IGF-I receptors, and possibly prevent apoptosis. In OxLDL-loaded macrophages, it has been hypothesized that GHRP-2 may reduce lipid accumulation, thereby emphasizing its expected antioxidant and protective effects in situations where blood and nutrient supply are compromised.




    GHRP-2 and the Immune System


    GHRP-2 peptide researchers believe that the peptide may enhance the function of the thymus, an organ that helps protect and mature certain cells of the immune system, particularly T lymphocytes. [5] T lymphocytes are essential for adaptive immunity and the physiological ability to fight complex infections. However, the efficacy of the thymus can be reduced, which can lead to tissue damage and decreased immunity. In this context, GHRP-2 appears to have the potential to rejuvenate the thymus, potentially promoting the number and diversity of T cells, thereby supporting general immunity.

    GHRP-2 and pain perception


    Researchers initially hypothesized that GHRP-2 might reduce pain associated with osteoarthritis in animal models by stimulating the production of growth hormone and the repair of damaged tissue. However, it has since been proposed that GHRP-2 might relieve pain before tissue repair occurs, perhaps due to actions on opioid receptors. There are four known opioid receptors. [6] Other compounds studied for their effects on opioid receptors often appear to have general effects on all four receptors. General modes of action can present challenges because receptors can have different and diverse functions. GHRP-2 appears to be a selective opioid receptor agonist that uniquely binds to receptors involved in pain perception, reward system connections, and sedation.